Published in
Elsevier, Cancer Treatment Reviews, (69), p. 233-242, 2018
DOI: 10.1016/j.ctrv.2018.06.008
Links
Tools
Clinical benefit of controversial first line systemic therapies for advanced stage ovarian cancer – ESMO-MCBS scores
Journal article published in 2018 by
K. E. Broekman,
M. Jalving,
H. van Tinteren 
,
C. Sessa,
A. K. L. Reyners
,
C. Sessa,
A. K. L. Reyners
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 